GlassScriptPhysician profile
Ravi Kumar Patel
NPI 1841633286
$26,900.13
in general payments reported to CMS, 2019-2025
90 companies · $4,721 in 2025
The $4,721 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $814 · 2021: $2,912 · 2022: $8,092 · 2023: $4,872 · 2024: $4,760 · 2025: $4,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,246.41 |
| Education | $1,106.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Labcorp Holdings INC. | $4,095.27 | 2022 | |
| Janssen Biotech, INC. | $2,065.17 | 2021-2025 | Tecvayli, Darzalex, Erleada |
| Astrazeneca Pharmaceuticals LP | $2,033.35 | 2019-2025 | Tagrisso, Enhertu, Lynparza |
| Pfizer INC. | $1,657.71 | 2020-2025 | |
| Celgene Corporation | $1,087.82 | 2020-2025 | Reblozyl, Pomalyst, Opdivo |
| Astellas Pharma US INC | $932.08 | 2021-2025 | Xtandi, Padcev, Vyloy |
| Genzyme Corporation | $923.60 | 2020-2025 | |
| Genentech USA, INC. | $768.40 | 2019-2025 | Tecentriq, Venclexta, Phesgo |
| Daiichi Sankyo INC. | $711.93 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Incyte Corporation | $688.94 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Glaxosmithkline, LLC. | $679.24 | 2020-2025 | Jemperli, Zejula, Ojjaara |
| Merck Sharp & Dohme LLC | $646.94 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $613.83 | 2021-2025 | |
| Amgen INC. | $561.33 | 2020-2023 | Lumakras, Kyprolis, Xgeva |
| E.R. Squibb & Sons, L.L.C. | $554.20 | 2019-2024 | Opdivo, Opdualag, Krazati |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $552.81 | 2021-2025 | Retevmo, Jaypirca, Verzenio |
| Exelixis INC. | $474.69 | 2020-2025 | Cabometyx |
| Abbvie INC. | $470.70 | 2021-2025 | |
| Seagen INC. | $463.40 | 2020-2025 | Tukysa, Adcetris, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $457.96 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $448.42 | 2020-2025 | Zepzelca |
| Regeneron Healthcare Solutions, INC. | $399.34 | 2021-2025 | Libtayo, Lynozyfic |
| Ipsen Biopharmaceuticals, INC | $339.14 | 2021-2025 | Onivyde, Somatuline Depot, Tazverik |
| Medtronic, INC. | $314.00 | 2024-2025 | Osteocool Rf Ablation System, Interstim |
| Pharmacyclics LLC, An Abbvie Company | $310.42 | 2020-2023 | Imbruvica, Epkinly |
| Eisai INC. | $293.64 | 2021-2025 | |
| Karyopharm Therapeutics INC. | $290.42 | 2020-2025 | Xpovio |
| Sun Pharmaceutical Industries INC. | $249.51 | 2022-2024 | |
| Array Biopharma INC | $246.54 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Coherus Oncology, INC. | $214.75 | 2021-2025 | Loqtorzi |
| Servier Pharmaceuticals LLC | $213.53 | 2022-2025 | |
| Sobi, INC | $190.59 | 2022-2025 | |
| Adc Therapeutics America, INC. | $164.75 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $144.67 | 2022-2024 | Ultomiris |
| Pharmaessentia USA Corporation | $126.50 | 2023-2025 | Besremi |
| Takeda Pharmaceuticals U.S.A., INC. | $124.70 | 2023-2025 | Alunbrig, Ninlaro, Iclusig |
| Pharmacosmos Therapeutics INC. | $110.85 | 2022-2025 | Monoferric, Cosela |
| Tempus Ai, INC | $110.60 | 2024-2025 | Xt Cdx |
| Mirati Therapeutics, INC. | $108.99 | 2023 | Krazati |
| Emd Serono, INC. | $108.29 | 2024-2025 | |
| Aveo Pharmaceuticals, INC. | $99.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.72 | 2020-2025 | |
| Deciphera Pharmaceuticals INC. | $85.89 | 2021-2025 | Qinlock, Romvimza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.63 | 2020 | |
| Tersera Therapeutics LLC | $70.53 | 2023-2024 | Zoladex |
| Puma Biotechnology, INC. | $69.07 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $63.72 | 2023-2025 | Alymsys, Neulasta, Neupogen |
| Myriad Genetic Laboratories, INC. | $62.21 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $61.60 | 2022-2024 | Sylvant |
| Stemline Therapeutics INC. | $61.19 | 2023-2025 | Orserdu |
| Kite Pharma, INC. | $58.81 | 2024-2025 | Yescarta |
| Acrotech Biopharma INC. | $53.82 | 2022-2024 | Beleodaq, Ryzneuta |
| Agios Pharmaceuticals, INC. | $52.25 | 2022-2024 | Pyrukynd |
| Menarini Silicon Biosystems, INC. | $51.20 | 2025 | |
| Sumitomo Pharma America, INC. | $50.81 | 2023-2025 | Orgovyx |
| Taiho Oncology, INC. | $49.38 | 2020-2022 | |
| Tolmar, INC. | $49.26 | 2023-2025 | Rubraca |
| Elekta, INC. | $46.78 | 2025 | Elekta Medical Linear Accelerator |
| Legend Biotech USA INC. | $44.36 | 2025 | Carvykti |
| Beigene USA, INC. | $44.26 | 2024 | Brukinsa |
| Geron Corporation | $43.62 | 2025 | Rytelo |
| Kyowa Kirin, INC. | $41.57 | 2021-2025 | |
| Cumberland Pharmaceuticals, INC. | $37.92 | 2024 | Sancuso |
| Accord Healthcare, INC. | $37.49 | 2024 | |
| Caris Mpi, INC. | $36.76 | 2025 | Mi Cancer Seek |
| Azurity Pharmaceuticals, INC. | $29.64 | 2025 | Danziten |
| Novocure INC. | $25.96 | 2024 | Optune Lua (Novottf-200t) |
| Biocon Biologics INC | $25.01 | 2024 | Fulphila |
| Organon LLC | $24.30 | 2024 | |
| Foundation Medicine, INC. | $23.13 | 2023 | |
| Mylan Institutional INC. | $23.12 | 2023 | Hulio |
| Cti Biopharma Corp. | $22.21 | 2023 | Vonjo |
| Acceleron Pharma, INC. | $21.99 | 2020 | |
| Alnylam Pharmaceuticals INC. | $21.51 | 2022 | |
| Iovance Biotherapeutics, INC. | $21.44 | 2025 | Amtagvi |
| Genmab U.S., INC. | $20.86 | 2024 | Epkinly |
| Blueprint Medicines Corporation | $20.62 | 2023 | Ayvakit |
| Pharmaand Gmbh | $20.62 | 2025 | Rubraca |
| Fennec Pharmaceuticals, INC. | $20.45 | 2024 | Pedmark |
| Eusa Pharma (US) LLC | $19.88 | 2022 | |
| G1 Therapeutics, INC. | $19.61 | 2023 | Cosela |
| Rigel Pharmaceuticals, INC. | $18.75 | 2023 | Rezlidhia, Tavalisse |
| Blue Earth Diagnostics | $18.36 | 2024 | |
| Dendreon Pharmaceuticals LLC | $18.08 | 2025 | Provenge |
| Beone Medicines USA, INC. | $18.01 | 2025 | Brukinsa |
| Teva Pharmaceuticals USA, INC. | $17.81 | 2019 | |
| Clovis Oncology, INC. | $15.40 | 2021 | |
| Immunogen, INC. | $14.88 | 2023 | Elahere |
| Dova Pharmaceuticals | $12.41 | 2021 | |
| Myovant Sciences INC. | $11.26 | 2021 |
Drugs and devices associated with these payments
Tecvayli $779Xtandi $737Darzalex $679Enhertu $492Reblozyl $433Erleada $407Talzenna $385Orgovyx $349Libtayo $340Keytruda $325Tagrisso $315Tukysa $308Sarclisa $298Jemperli $286Nubeqa $279Talvey $270Adcetris $269Imbruvica $262Lenvima $250Venclexta $248Xofigo $237Elrexfio $236Zepzelca $227Jakafi $227Ibrance $225Retevmo $221Inlyta $217Jaypirca $206Bosulif $206Braftovi $198Kisqali $192Padcev $191Opdivo $181Mektovi $177Zejula $175Osteocool Rf Ablation System $175Lynparza $174Rybrevant $173Injectafer $171Carvykti $169Ojjaara $161Elahere $156Vonjo $145Onivyde $140Lorbrena $139Interstim $139Epkinly $131Krazati $130Besremi $127Pluvicto $124Ultomiris $122Xt Cdx $111Xpovio $110Udenyca $110Balversa $109Verzenio $107Lutathera $104Promacta $102Lumakras $101Tibsovo $95.47Somatuline Depot $93.62Kyprolis $86.01Akeega $85.68Cablivi $85.49Piqray $84.48Jevtana $82.77Alunbrig $73.93Monoferric $73.50Opdualag $73.41Comirnaty $73.23Cabometyx $73.11Zoladex $70.53Enjaymo $65.02Paxlovid $64.56Tivdak $64.43Tecentriq $64.33Pomalyst $62.59Brukinsa $62.27Orserdu $61.19Yescarta $58.81Qinlock $58.65Datroway $56.83Xgeva $52.96Cellsearch $51.20Welireg $47.14Elekta Medical Linear Accelerator $46.78Idhifa $46.63Tazverik $46.04Alymsys $44.46Phesgo $43.72Rytelo $43.62Vitrakvi $41.80Stivarga $41.80Sylvant $41.73Cosela $41.40Rubraca $39.96Vyloy $38.11Sancuso $37.92Camcevi $37.49Riabni $37.09
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.